Skip to content
Screener

Cardiff Oncology CRDF Q4 2025 Annual earnings

Reported February 24, 2026 · After market close

Revenue$243.0KBeat by $139.5K
EPS-$0.11Beat by $0.07
Revenue estimate$103.5K
EPS estimate-$0.18

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$67.2K
EPS estimate-$0.15

FAQ

When did Cardiff Oncology report Q4 2025 earnings?
Cardiff Oncology (CRDF) reported Q4 2025 earnings on February 24, 2026 after market close.
What were Cardiff Oncology's Q4 2025 revenue and EPS?
Cardiff Oncology reported revenue of $243.0K and eps of $-0.11 for Q4 2025.
Did Cardiff Oncology beat estimates in Q4 2025?
Revenue beat the consensus estimate of $103.5K by $139.5K. EPS beat the consensus estimate of $-0.18 by $0.07.
How did Cardiff Oncology's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 60.9% from $151.0K a year earlier and eps grew 47.6% from $-0.21.
Where can I find Cardiff Oncology's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-067476) and the 10-K periodic report (0001193125-26-067464) directly on SEC EDGAR. The filing index links above go to sec.gov.